ArticlePharmaceutics2022

Development and Evaluation of a PSMA-Targeted Nanosystem Co-Packaging Docetaxel and Androgen Receptor siRNA for Castration-Resistant Prostate Cancer Treatment.

Yingying Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.